Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Canada and Latin America: $3,675M in FY2025, up 2.3% from a year earlier.
Latest, FY2025
3,675
Period ended Dec 31, 2025
Change on a year earlier
+2.3%
3,593 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Canada and Latin America | 3 675 | 3 593 | 2 | 13 | 6 | 7”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Canada and Latin America ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,675 | +2.3% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 3,593 | +13.1% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 3,176 | +8.7% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 2,922 | +5.0% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 2,782 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up canada and Latin America
Cite this data
StockData. (2026). Novartis Canada and Latin America ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-canada-latam
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.